Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Clinical evidence that a dysregulated master neural network modulator may aid in diagnosing schizophrenia.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 31, 2021
Valproate reverses mania-like behaviors in mice via preferential targeting of HDAC2.
Journal: Molecular psychiatry
Published: July 22, 2020
The Evolution of Stem Cells, Disease Modeling, and Drug Discovery for Neurological Disorders.
Journal: Stem cells and development
Published: February 07, 2020
Discovery of suppressors of CRMP2 phosphorylation reveals compounds that mimic the behavioral effects of lithium on amphetamine-induced hyperlocomotion.
Journal: Translational psychiatry
Published: July 11, 2019
Modeling Complex Neurological Diseases with Stem Cells: A Study of Bipolar Disorder.
Journal: Results and problems in cell differentiation
Published: September 14, 2018
Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 14, 2017
Implications and limitations of cellular reprogramming for psychiatric drug development.
Journal: Experimental & molecular medicine
Published: August 21, 2013
Combined total proteomic and phosphoproteomic analysis of human pluripotent stem cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 13, 2013
Three-dimensional scaffolding to investigate neuronal derivatives of human embryonic stem cells.
Journal: Biomedical microdevices
Published: July 07, 2012
Phosphoproteomic analysis: an emerging role in deciphering cellular signaling in human embryonic stem cells and their differentiated derivatives.
Journal: Stem cell reviews and reports
Published: October 20, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026